CTOs on the Move

Surgical Care Affiliates

www.scasurgery.com

 
SCA`s vision is to be the partner of choice for physicians, hospitals, and health systems in developing and operating ambulatory surgery centers and surgical hospitals across the country and in enhancing hospital-based surgical departments. SCA owns and/or provides management services to 210 ambulatory surgery centers, surgical hospitals, and hospital surgery departments, in partnership with approximately 7,500 physicians and in affiliation with 110 health systems. SCA`s clinical systems, service line growth strategies, benchmarking processes, and efficiency programs create measurable advantage for surgical facilities – clinically, operationally, and financially.
  • Number of Employees: 1K-5K
  • Annual Revenue: $500M-1 Billion

Executives

Name Title Contact Details
Anthony Williams
Chief Information Officer Profile
Mervyn Chapman
Director - Information Security Profile

Similar Companies

Cross Tree Capital

Cross Tree Capital is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dedicated Clinical Research II-IV

Dedicated Clinical Research II-IV is a Litchfield Park, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VASAMED, Inc.

VASAMED, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Eden Prairie, MN. To find more information about VASAMED, Inc., please visit www.vasamed.com

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.

Hunstman Expandable Polymers Co.

Hunstman Expandable Polymers Co. is a High Point, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.